Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preemptive tizanidine analgesia in total knee arthroplasty
ChiCTR2500104341Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in knee osteoarthritis (OA) comparing Tizanidine preemptive analgesia with Placebo (2 arms). Primary endpoint: Morphine consumption for remedial analgesia during postoperative hospital stay. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
tizanidine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2500104341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104341.